These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 29066853)

  • 1. Non-invasive quantitative imaging of hepatocellular carcinoma growth in mice by micro-CT using liver-targeted iodinated nano-emulsions.
    Anton N; Parlog A; Bou About G; Attia MF; Wattenhofer-Donzé M; Jacobs H; Goncalves I; Robinet E; Sorg T; Vandamme TF
    Sci Rep; 2017 Oct; 7(1):13935. PubMed ID: 29066853
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Image fusion with volume navigation of contrast enhanced ultrasound (CEUS) with computed tomography (CT) or magnetic resonance imaging (MRI) for post-interventional follow-up after transcatheter arterial chemoembolization (TACE) of hepatocellular carcinomas (HCC): Preliminary results.
    Ross CJ; Rennert J; Schacherer D; Girlich C; Hoffstetter P; Heiss P; Jung W; Feuerbach S; Zorger N; Jung EM
    Clin Hemorheol Microcirc; 2010; 46(2-3):101-15. PubMed ID: 21135486
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comprehensive Comparison of Multiple-Detector Computed Tomography and Dynamic Magnetic Resonance Imaging in the Diagnosis of Hepatocellular Carcinoma with Varying Degrees of Fibrosis.
    Lin MT; Wang CC; Cheng YF; Eng HL; Yen YH; Tsai MC; Tseng PL; Chang KC; Wu CK; Hu TH
    PLoS One; 2016; 11(11):e0166157. PubMed ID: 27829060
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of biannual ultrasonography and annual non-contrast liver magnetic resonance imaging as surveillance tools for hepatocellular carcinoma in patients with liver cirrhosis (MAGNUS-HCC): a study protocol.
    Kim HA; Kim KA; Choi JI; Lee JM; Lee CH; Kang TW; Ku YM; Lee SL; Park YS; Yoon JH; Kim SH; Choi MH
    BMC Cancer; 2017 Dec; 17(1):877. PubMed ID: 29268722
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Time course of contrast enhancement by micro-CT with dedicated contrast agents in normal mice and mice with hepatocellular carcinoma: comparison of one iodinated and two nanoparticle-based agents.
    Rothe JH; Rudolph I; Rohwer N; Kupitz D; Gregor-Mamoudou B; Derlin T; Furth C; Amthauer H; Brenner W; Buchert R; Cramer T; Apostolova I
    Acad Radiol; 2015 Feb; 22(2):169-78. PubMed ID: 25282584
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contrast ultrasound LI-RADS LR-5 identifies hepatocellular carcinoma in cirrhosis in a multicenter restropective study of 1,006 nodules.
    Terzi E; Iavarone M; Pompili M; Veronese L; Cabibbo G; Fraquelli M; Riccardi L; De Bonis L; Sangiovanni A; Leoni S; Zocco MA; Rossi S; Alessi N; Wilson SR; Piscaglia F;
    J Hepatol; 2018 Mar; 68(3):485-492. PubMed ID: 29133247
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intraperitoneal injections as an alternative method for micro-CT contrast enhanced detection of murine liver tumors.
    Sweeney N; Marchant S; Martinez JD
    Biotechniques; 2019 May; 66(5):214-217. PubMed ID: 31050302
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Noninvasive imaging of hepatocellular carcinoma: From diagnosis to prognosis.
    Jiang HY; Chen J; Xia CC; Cao LK; Duan T; Song B
    World J Gastroenterol; 2018 Jun; 24(22):2348-2362. PubMed ID: 29904242
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LI-RADS-CEUS - Proposal for a Contrast-Enhanced Ultrasound Algorithm for the Diagnosis of Hepatocellular Carcinoma in High-Risk Populations.
    Schellhaas B; Wildner D; Pfeifer L; Goertz RS; Hagel A; Neurath MF; Strobel D
    Ultraschall Med; 2016 Dec; 37(6):627-634. PubMed ID: 27486793
    [No Abstract]   [Full Text] [Related]  

  • 10. Neovascularization of hepatocellular carcinoma in a nude mouse orthotopic liver cancer model: a morphological study using X-ray in-line phase-contrast imaging.
    Li B; Zhang Y; Wu W; Du G; Cai L; Shi H; Chen S
    BMC Cancer; 2017 Jan; 17(1):73. PubMed ID: 28122521
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CEUS: An essential component in a multimodality approach to small nodules in patients at high-risk for hepatocellular carcinoma.
    Jang HJ; Kim TK; Burns PN; Wilson SR
    Eur J Radiol; 2015 Sep; 84(9):1623-35. PubMed ID: 26092406
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnosis and staging of hepatocellular carcinoma (HCC): current guidelines.
    Ayuso C; Rimola J; Vilana R; Burrel M; Darnell A; García-Criado Á; Bianchi L; Belmonte E; Caparroz C; Barrufet M; Bruix J; Brú C
    Eur J Radiol; 2018 Apr; 101():72-81. PubMed ID: 29571804
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Staging of hepatocellular carcinoma. Comparison of ultrasonography, computerized tomography, magnetic resonance, digital angiography, and computerized tomography with lipiodol].
    Bartolozzi C; Lencioni R; Caramella D; Gibilisco G; Cioni R; Vignali C
    Radiol Med; 1994 Oct; 88(4):429-36. PubMed ID: 7997616
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical value of dynamic 3-dimensional contrast-enhanced ultrasound imaging for the assessment of hepatocellular carcinoma ablation.
    Wang Y; Jing X; Ding J
    Clin Imaging; 2016; 40(3):402-6. PubMed ID: 27133676
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dynamic Volume Assessment of Hepatocellular Carcinoma in Rat Livers Using a Clinical 3T MRI and Novel Segmentation.
    Orci LA; Oldani G; Lacotte S; Slits F; Friedli I; Wirth W; Toso C; Vallée JP; Crowe LA
    J Invest Surg; 2018 Feb; 31(1):44-53. PubMed ID: 28107094
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ultrasonography, computed tomography and magnetic resonance imaging of hepatocellular carcinoma: toward improved treatment decisions.
    Murakami T; Imai Y; Okada M; Hyodo T; Lee WJ; Kim MJ; Kim T; Choi BI
    Oncology; 2011; 81 Suppl 1():86-99. PubMed ID: 22212941
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection and characterization of focal liver lesions: a Japanese phase III, multicenter comparison between gadoxetic acid disodium-enhanced magnetic resonance imaging and contrast-enhanced computed tomography predominantly in patients with hepatocellular carcinoma and chronic liver disease.
    Ichikawa T; Saito K; Yoshioka N; Tanimoto A; Gokan T; Takehara Y; Kamura T; Gabata T; Murakami T; Ito K; Hirohashi S; Nishie A; Saito Y; Onaya H; Kuwatsuru R; Morimoto A; Ueda K; Kurauchi M; Breuer J
    Invest Radiol; 2010 Mar; 45(3):133-41. PubMed ID: 20098330
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fluorine-18 FDG positron emission tomography for imaging of hepatocellular carcinoma.
    Trojan J; Schroeder O; Raedle J; Baum RP; Herrmann G; Jacobi V; Zeuzem S
    Am J Gastroenterol; 1999 Nov; 94(11):3314-9. PubMed ID: 10566736
    [TBL] [Abstract][Full Text] [Related]  

  • 19. EUS for detection of the hepatocellular carcinoma: results of a prospective study.
    Singh P; Erickson RA; Mukhopadhyay P; Gopal S; Kiss A; Khan A; Ulf Westblom T
    Gastrointest Endosc; 2007 Aug; 66(2):265-73. PubMed ID: 17543307
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Usefulness of contrast-enhanced intraoperative ultrasound using Sonazoid in patients with hepatocellular carcinoma.
    Arita J; Takahashi M; Hata S; Shindoh J; Beck Y; Sugawara Y; Hasegawa K; Kokudo N
    Ann Surg; 2011 Dec; 254(6):992-9. PubMed ID: 21694582
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.